应对痴呆症改变的日常生活:我们可以从那些在工作期间被诊断出患有痴呆症的人身上学到什么?
Louise Nygård1, Ann-Charlotte Nedlund2, Mervi Issakainen3
1Division of Occupational Therapy, NVS, Karolinska Institutet, Stockholm, Sweden.
Dementia (London, England)
|February 26, 2025
概括
患有痴呆症的人通过专注于他们的能力和身份来探索持续参与活动. 支持他们的机构对于在早期痴呆症期间管理生活变化至关重要.
科学领域:
- 老年学是一门学科.
- 职业疗法 职业疗法 职业疗法
- 痴呆症研究 痴呆症研究
背景情况:
- 在工作年期间诊断痴呆症带来了独特的挑战.
- 对于患有痴呆症的人来说,了解从工作生活过渡至关重要.
研究的目的:
- 探索被诊断患有痴呆症的工作人员如何在日常生活中的变化中进行导航.
- 了解他们理解和接受退出工作生活的过程.
主要方法:
- 探索性,纵向研究设计.
- 与五名参与者进行了定性,深入的访谈.
- 使用做,存在,成为和归属的概念的解释方法.
主要成果:
- 参与者寻求基于感知能力和理想身份的持续活动参与.
- 主题包括指导活动,与诊断相关,以及管理福祉.
- 调查结果强调了人们感知的能力,身份和归属的重要性.
结论:
- 参与者在适应生活变化方面表现出强大的行动力.
- 代理是至关重要的,可以在患有早期痴呆症的人群中得到支持.
- 在工作,私人生活,医疗保健和痴呆症协会中需要支持性努力.
相关概念视频
Cognitive Development During Adulthood
44
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
44
Dementia
88
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
88
Alzheimer's Disease: Overview
422
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
422
Intellectual Disability
34
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
34
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
1.5K
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
1.5K
Alzheimer's Disease: Treatment
147
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
147


